Allstate Corp (ALL)

ALL (NYSE:Insurance) EQUITY
$70.61
pos +0.00
+0.00%
Today's Range: 70.26 - 70.78 | ALL Avg Daily Volume: 2,294,100
Last Update: 12/02/16 - 4:01 PM EST
Volume: 0
YTD Performance: 12.61%
Open: $0.00
Previous Close: $70.35
52 Week Range: $56.03 - $72.72
Oustanding Shares: 368,246,845
Market Cap: 25,906,165,546
6-Month Chart
TheStreet Ratings Grade for ALL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.83 1.83 1.83 1.83
Latest Dividend: 0.33
Latest Dividend Yield: 1.88%
Dividend Ex-Date: 11/28/16
Price Earnings Ratio: 19.06
Price Earnings Comparisons:
ALL Sector Avg. S&P 500
19.06 19.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.08% 12.51% 28.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.20 0.10 0.02
Net Income -23.80 -0.10 -0.02
EPS -19.50 0.10 0.03
Earnings for ALL:
EBITDA 3.57B
Revenue 35.65B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.56 $1.62 $4.23 $6.13
Number of Analysts 8 7 10 10
High Estimate $1.80 $1.89 $4.46 $6.75
Low Estimate $1.34 $0.98 $3.85 $5.32
Prior Year $1.60 $0.84 $5.19 $4.23
Growth Rate (Year over Year) -2.50% 93.37% -18.57% 44.96%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Jim Cramer

 | Nov 2, 2016 | 3:10 PM EDT
I'm talking about head-to-head comparisons of companies.
By

Anders Keitz

 | Oct 26, 2016 | 11:00 AM EDT
Stock soars 138% over 12 months as U.S. pet-insurance sector grows.
By

Roger Arnold

 | Jul 26, 2016 | 3:00 PM EDT
Investors may finally be catching up to it.
RMPIA
By

Doug Kass

 | Apr 7, 2016 | 4:44 PM EDT
The U.S. dollar weakened. Our currency has had a big run and I wouldn't be surprised if some profit-taking occurred, as mentioned yesterday. Bonds bolted higher in a flight to safety. iShares 20+ Year Treasury Bond (TLT) was up $1.70. The yield on the 10-year U.S. note dropped by seven basis points to 1.68% and the long bond declined to 2.51%. For some time I have emphasized that stock investors should heed the message from the bond market, both here and abroad. I continue to see a 35% chance of a garden-variety recession in 2016-17 and a 15% chance of a deeper recession. Municipals were well-bid and closed-end municipal bond funds continued higher. High yield was junky. However, Blackstone/GSO Strategic Credit Fund (BGB) was up a few pennies. Gold rose by $18 to $1,242. Crude oil declined by a quarter to $39.60.  Nat gas rose by eleven cents. Agricultural commodities: wheat -5.25, corn +3.50, soybeans -4.00. Banks got whacked big-time. As you all know, I sold out all of my longs about a week ago as I am fearful that earnings estimates are too high. I lowered my earnings-per-share expectations by 5% on Monday. We could see a buying opportunity on the next leg lower (if it occurs) in response to disappointing first-quarter earnings. Spreads, loan losses and weak capital markets activity will likely be the culprits. Brokerages got ripped apart, especially my lone short Goldman Sachs (GS), which I just put on Tuesday and Wednesday. GS was down $4.82 and Morgan Stanley (MS) down 62 cents. GS has some fans on the site, but I respectfully disagree. Energy stocks got taken to the woodshed. Schlumberger (SLB) down $1.15 and Exxon Mobil (XOM) down 95 cents. Life insurance, the object of my disaffection, faces huge reinvestment problems and today's bond rally hit the sector badly. Lincoln National (LNC) was down $1.12 and MetLife (MET) down $1.14. Berkshire Hathaway (BRK.B) got hit again. Retail was weak, led by my sole short position Nordstrom (JWN), down $2.25 -- it also has been endorsed on the site.  Autos continue to founder -- Ford (F) down 30 cents and General Motors down 50 cents; they continue to act like value traps. Peak autos is my continued mantra. Old tech got hit, led down by IBM (IBM), off $1.80, Intel (INTC), Microsoft (MSFT) and Cisco (CSCO). Consumer non-durables got hit. My long Procter & Gamble (PG) was down 70 cents and short Coca-Cola (KO) was down 47 cents. Biotech reversed yesterday's spectacular gains; iShares Nasdaq Biotechnology (IBB) was down $4.80. My biotech basket was mixed to down. Old media suffered -- Comcast (CMCSA) and Disney (DIS) down for a second day in a row as a result of management issues. (T)FANG got whacked, led by Amazon (AMZN) and Telsa (TSLA) -- each down by more than $8. NOSH threw up. Home Depot (HD) and O'Reilly Automotive (ORLY) were on the downside. CRABBY was down, led by drops in Alleghany (Y) and Allstate (ALL). In individual stocks, DuPont (DD) is $1 to $2 within my buy zone. Here is some good stuff on RealMoneyPro today: Ben "Goldfinger" Cross on "Gold Benefits as Stocks Weaken"  Rev Shark on "My Kind of Market Could Be Setting Up"  S
RMPIA
By

Doug Kass

 | Mar 3, 2016 | 2:59 PM EST
The U.S. dollar weakened today. Government bonds dropped by two to three basis points in yield. The 10-year yields 1.83% and the long bond 2.66%. Municipals were flat, as was high yield. Blackstone/GSO Strategic Credit Fund (BGB) was up a few pennies. Crude oil rose by two cents to $34.68. Nat gas was two cents lower. In agricultural commodities, wheat rose by 8.50 and oats 7.00, but soybeans were only up 2.00 Corn was flat. Shares of Potash (POT) recently have benefited from higher ag prices. Gold ramped to $1,258, up $16.40). Silver was up 15 cents. Financials were firm, and bank stocks slightly higher (I reduced positions yesterday). Comerica (CMA) looks to be breaking out from its trading range, up $1.25 today. Life insurance stocks were well-bid. I shorted MetLife (MET) and Lincoln National (LNC) yesterday. Brokerages were stronger, led by long holding Goldman Sachs (GS). Morgan Stanley (MS) was flat. Old tech was mixed, with IBM (IBM) up and Microsoft (MSFT) down. Biotech returned to underperformance today, with Valeant Pharmaceuticals (VRX) and Allergan (AGN) very weak. I sold my entire Biotech Basket yesterday for a nice gain. In the basket, Aerie Pharmaceuticals (AERI), down 17%, and Celgene (CELG), down $1.71, led on downside while Interxon (XON) continued to gain after yesterday's outsize move higher. Retail was broadly higher; Best Ideas List stock Bed, Bath & Beyond (BBBY) was up almost 3%. Macy's (M) is back near its high and Best Buy (BBY) was trending higher as well. Media is well-bid. My shorts Comcast (CMCSA) and Disney (DIS) are higher. Consumer staples were mixed; Procter & Gamble (PG) was higher but Kimberly-Clark (KMB) lower. Autos are strong today, with Ford (F) up 25 cents and General Motors (GM) up 80 cents. (T)FANG might be flailing. Only Tesla (TSLA) is up on the day, but the losses have been contained. NOSH lower, led by Nike (NKE) to the downside. CRABBY was well-bid, with only Alleghany (Y) lower. Twitter (TWTR) continues its rise from sub-$14; it's now over $19. Starbucks (SBUX), a short, is off 70 cents. Blackstone Group (BX), though slightly lower, is holding on to its nice recent gains.  I re-shorted SLB and XOM and placed these energy names on my Best Ideas List as shorts. I sold Allstate (ALL) after a $9 move up from the market's recent lows.  I have increased my net short exposure today.
By

Doug Kass

 | Mar 3, 2016 | 11:20 AM EST
I've eliminated my long of Allstate (ALL).
By

Bruce Kamich

 | Mar 3, 2016 | 8:27 AM EST

The low $70s is our upside target.

RMPIA
By

Doug Kass

 | Mar 1, 2016 | 4:05 PM EST
The U.S. dollar strengthened modestly. Crude oil increased by 66 cents to $34.41. Gold was flat. Agricultural commodities saw wheat, soybean and corn trade up. Bonds got blasted, with the iShares 20+ Year Treasury Bond ETF (TLT) down $2.50) -- an important feature of the day. Longer-dated yield increased by about eight basis points and the yield curve, as an aid to bank stocks, steepened. Municipals got hit. High yield continued to rally after starting the day lower. Blackstone/GSO Strategic Credit Fund (BGB), the object of my affection yesterday (I noted last week's junk bond inflows) and almost every day, rose 31 cents to $12.73. I highlighted BGB yesterday as a favored idea.   Banks were the world's fair after several days of underperformance. The sector recorded a 4% to 5% gain, highlighted by the three money center banks, Citigroup (C), Bank of America (BAC) and JPMorgan Chase (JPM). I have seven banks stocks on my Best Ideas List.  Brokerages and private equity were also strong, with Goldman Sachs (GS) up $4.50, Morgan Stanley (MS) up $1.25 and Blackstone Group (BX) up $1.25. All three are on my Best Ideas List.  Insurance stocks ripped higher. I am offering Lincoln National (LNC) and MetLife (MET) to re-establish my shorts. Berkshire Hathaway (BRK.B) was up in my face but Hartford Financial Services Group (HIG) and Allstate (ALL) are trading well. Retail was strong, led by Bed, Bath & Beyond (BBBY) up $1.40 and Macy's (M) making a new recent high near $44 a share. Consumer staples were led by Procter & Gamble (PG), up $1, Colgate-Palmolive (CL), up $1.65, and Kimberly-Clark (KMB) +$1.35. Old tech prospered, with IBM (IBM) up $3.40; Intel (INTC), Cisco (CSCO) and Microsoft (MSFT) were up nearly 3% each. Autos were strong, but no better than the opening. I shorted General Motors (GM) and Ford (F). Here is my rationale for "Peak Autos." From Peter Boockvar: According to Ward's Automotive, February vehicle sales totaled 17.43mm SAAR vs 17.46mm in January and below the estimate of a lift to 17.70mm. After 3 straight months of 18mm+ in September thru November, the last 3 months have been in the 17mm range. The question of peak auto sales is becoming more front and center as via easy access to credit we've pulled forward a lot of potential future sales. Over the weekend the WSJ reported that in Q4, "auto loans that are 30-89 days overdue rose to 1.82% of total auto loans...the highest level since 2011." The article stressed that this ratio reflected auto loans kept on bank balance sheets which are typically the better credits as opposed to those off loaded into an ABS. For ABS, Fitch last week said that "delinquencies of over 60 days on securities backed by subprime auto loans hit almost 5% in January. That is the highest since September 2009 and close to the record peak hit that same year." Biotech even rallied after conspicuous recent underperformance, up 4% with Allergan (AGN) and AbbVie (ABBV) leading. Valeant Pharmaceuticals (VRX) even reversed but still was in the red. My Biotech Basket was broadly higher, led by Acadia Pharmaceuticals (ACAD), Celgene (CELG), Gilead Sciences (GILD), Portola Pharmaceuticals (PTLA), Otonomy (OTIC) up 8% and Interxon (XON) up $2.50. (T)FANG, ex Tesla (TSLA) -- Citron report hurt -- was broadly higher.   NOSH's four components drove higher, too. CRABBY broadly up, with C and BGB leading. Serial portfolio laggards are beginning to catch up -- Radian Group (RDN) up 5% and Potash (POT) up 50 cents. Apple (AAPL), a short, caught up and is trading close to par, even though Cleveland Research has cautious comments. I identified DuPont (DD) as one of my favorite stocks of the year, and it rose by $2 today, to a new recent high. Net net, I added small to my net short exposure, but I added to longs and to shorts at the same time. I did average in further (on a scale -- cost under $21) on ProShares UltraShort S&P 500 (SDS). Here is some good stuff on RealMoneyPro today: Jim "El Capitan" Cramer's market map.  Sham Gad on value investing.  RevShark on a
By

Doug Kass

 | Mar 1, 2016 | 2:00 PM EST
I added to two lagging financials today: Allstate (ALL) and Hartford Financial (HIG).
By

Doug Kass

 | Feb 23, 2016 | 9:46 AM EST
The S&P 500's fair-market value is approximately 1,860. The Federal Reserve won't increase the fed funds rate this year. The likely 2016-17 economic outlook is somewhere between "muddle along" and a "garden-variety recession." As such, I've boosted my view of the energy and consumer-staples sectors to "Neutral" from a previous "Negative." I've also improved my take on retail and health care/biotech to "Positive" from an earlier "Neutral." Basic Materials/Industrials The materials sector has recently rallied significantly from its near-term lows. This has coincided with a broad sense that commodities' extended drop might be coming to an end, and that global economic growth -- although substandard by historic comparisons -- will muddle along. Still, I wouldn't chase basic materials and industrials after their sharp gains of the past two weeks. After all, I still have a lower-than-consensus forecast for domestic and global growth (see my recent column Fire and Ice). Other unknown factors include future levels of both the U.S. dollar -- as a strengthening currency is competition costly -- and energy prices, as costlier oil and other commodities could be headwinds to margins. So, let's stay alert for those. The slowing, fragile trajectory of global growth in a world that's held hostage to terrorism, other potentially upsetting factors and "black swans" will also likely continue to pressure industrials. That said, several factors -- including the emergence of more activist investors and the sector's weak share prices vs. year-ago levels -- could limit industrials/materials' downside. I recently added cyclical exposure with a

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.